Major players in the veterinary orthopedic implants market are KYON Pharma Inc. , Veterinary Orthopedic Implants Inc. , BioMedtrix LLC, IMEX Veterinary Inc. , Orthomed Ltd, Securos Surgical, B. Braun Vet Care, Bluesao, DePuy Synthes Vet, and MWI Veterinary Supply Co.
New York, May 30, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Veterinary Orthopedic Implants Global Market Report 2022" - https://www.reportlinker.com/p06280833/?utm_source=GNW The global veterinary orthopedic implants market is expected to grow from $0.21 billion in 2021 to $0.22 billion in 2022 at a compound annual growth rate (CAGR) of 7.9%. The market is expected to grow to $0.30 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The veterinary orthopedic implants market consists of sales of veterinary orthopedic implants and related services.Veterinary orthopedic implants are used by veterinary surgeons for bone fixation surgeries, treating bone fractures in animals, and are usually made of metals like pure commercial titanium (Ti) or titanium alloys, stainless steel, cobalt-chromium (Co-Cr) alloys. The orthopedic implants are also used as a support structure for healing fractures and reconstructive surgeries. Orthopedic implants include screws, plates, pins, and wires which are used in surgeries performed on animals. The main product types in veterinary orthopedic implants are advanced locking plate system, tibial plateau leveling osteotomy implants, tibial tuberosity advancement implants, total elbow replacement, total hip replacement, total knee replacement, and trauma fixations.A tibial plateau leveling osteotomy implants are used to repair cranial cruciate ligament rupture in dogs. The veterinary orthopedic implants are used for animals such as dog cats and others that are used by end-users such as veterinary hospitals, veterinary clinics, and veterinary surgical centers. The increase in the incidence of obesity and arthritis increases the demand for veterinary orthopedic implants market.Obesity is a condition where the weight of the pet affects the pet’s health to a point where it results in the weakening of bones, whereas arthritis in pets results in loss of strength in bones. Obesity and arthritis may also result in fractures and other bone-joint-related issues and both conditions result in adversely affecting the overall health of the pet, consequently leading to shortening lifespan.Thus, the increased incidents of obesity and arthritis increase the demand for veterinary orthopedic implants. According to Banfield Pet Hospital’s report on 2.5 million dogs and 500,000 cats treated in the USA, the number of osteoarthritis (OA) cases increased 66% in dogs and 150% in cats. The report also inferred that 52% of dogs and 41% of cats with OA are also overweight or obese. Thus, the increase in health conditions affecting the bones of pets such as obesity and arthritis positively affect the growth of the veterinary orthopedic market. The high cost of orthopedic surgery inhibits the growth of the veterinary orthopaedic implants market.The surgery cost includes the equipment, X-ray, and consumables among others, which many of the households cannot afford. For instance, in the USA, a typical examination of the problem costs around $400 and the cost of orthopaedic surgery ranges from $1,500 to $4,000. Thus, the high cost of orthopaedic surgery restricts the growth of the veterinary orthopaedic market. The companies in the veterinary orthopaedic implants market are investing in 3D printing techniques for creating veterinary orthopaedic implants. 3D printing in the veterinary orthopaedics market is being used for creating printed bone models, surgical guides, and titanium implants. The use of 3D printing reduces the surgical time, cost and removes the engineering complexities in orthopaedic procedures. Following the trend, many dogs with bone deformities have been treated by Langford Veterinary Services, a UK-based provider of veterinary services, through its collaboration with CBM. The collaboration enabled CBM to create 3D printed models of animal implants using titanium Ti6AI4V EL material. The MRI or CT scans are sent from Langford Veterinary Services in Bristol to CBM then produces 3D printed models using Arcam EBM Q10plus machine. CBM is a U.K based company focused on advanced research, product development, and batch manufacturing facility. Thus, the use of 3D printing is one of the latest trends in the veterinary orthopaedic implants market and will contribute to the growth of the market. In 2019, Infiniti Medical, a USA-based designer and distributor of medical devices for the veterinary market, acquired Orthomed Ltd. for an amount undisclosed. Through the acquisition, Infiniti Medical aims to expand its product portfolio by adding products and services from Orthomed. Orthomed Ltd is a UK-based provider of orthopedic products and systems in the veterinary industry. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the veterinary orthopedic implants are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. Read the full report: https://www.reportlinker.com/p06280833/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
The bear market sell-off worsened on fears that the Fed will trigger a recession to control inflation. Yields hit highs. Oil prices tumbled.
Alicia Munnell, head of the Boston College Center for Retirement Research, offers three ways to shore up the system: raise taxes to bolster Social Security, make workplace retirement plans available to all workers, and encourage many Americans to work longer.
Here's what to watch in the markets on Friday, June 17, 2022.
BMO Capital analyst David Gagliano lowered the price target on United States Steel Corp (NYSE: X) to $23 (an upside of 15.5%) from $30 while maintaining the Market Perform rating on the shares. X provided its 'mid-quarter' update yesterday and mentioned that it expects 2Q22 EBITDA of $1.6 billion, vs. BMO/FactSet consensus of $1.5 billion. Related: United States Steel Stock Gains On Strong Q2 Outlook The analyst states that this update has no major surprises, considering other better-than-expect
Mizuho Securities analyst Anthony Crowdell lowered the price target on WEC Energy Group Inc (NYSE: WEC) to $93 (an upside of 3%) from $107 while maintaining the Neutral rating on the shares. Mizuho hosted investor meetings with WEC’s Executive Chairman Gale Klappa and CFO Xia Liu. Crowdell says that the management highlighted the strong 6-7% EPS growth rate and its ability to deliver that without the need for operating adjustments. The analyst thinks that the high-quality earnings may continue t
(Bloomberg) -- Meta Platforms Inc. was sued over claims that private medical data is being shared secretly with Facebook when patients access web portals for some health-care providers.Most Read from BloombergPutin Gets Unexpected Pushback From Ally Over War in UkraineChina Says It May Have Detected Signals From Alien CivilizationsSergey Brin Seeks Divorce, Joining Gates and Bezos in SplitMusk, Tesla, SpaceX Are Sued for Alleged Dogecoin Pyramid SchemeMonkeypox Testing Shows the US Learned Littl
(Reuters) -European stocks edged higher on Friday, but posted their third straight week of losses as a slew of interest rate hikes from major central banks fuelled worries about a sharp economic slowdown. The pan-European STOXX 600 index rose 0.1% in volatile trade, but ended the week 4.6% lower. World stock markets were heading for their biggest weekly decline since a pandemic-induced meltdown in March 2020, hit by growing worries about a recession after rate increases in the United States and Britain were followed by a surprise move in Switzerland to quell an inflation surge.
The Bitcoin carnage continues, as the cryptocurrency breaks $20,000 to trade at its lowest level since 2020.
The major stock market indexes are all in the green on this last trading day before a long holiday weekend. Indexes are near the day's highs in the last hour of trading. The Nasdaq composite leads the day, up 1.
Gas prices are at a record high nationwide, but there are a few things consumers can to ease the pain at the pump.
Rising interest rates and a potential recession are also putting pressure on the sector.
The cryptocurrency market’s latest swoon has raised the specter of bankruptcy restructuring. In such a case, crypto investors would be navigating uncharted territory.
Why Mattel is MKM Partners’ top idea in media and entertainment. Also, Wall Street opinions on Hershey, Micron Technology, Arista Networks, Raytheon, and Continental Resources.
The S&P 500 has had another rough week, as we have slammed into the 200 week EMA.
Seeds and pesticides maker Syngenta, the Swiss agrochemicals company planning a $10 billion initial public offering (IPO), announced a new leader for its biggest business on Friday. Jeff Rowe, now President, Global Seeds, will take over the leadership of Syngenta Crop Protection, effective July 1. The job, in charge of Syngenta's biggest division which made up nearly half the group's $28.2 billion sales in 2021, could make Rowe a front-runner to eventually succeed Chief Executive Erik Fyrwald, aged 62.
Comments from the Fed chair were a reminder that the central bank is adamant about keeping a lid on inflation—and economic demand.
Brands discussed customer connection, creating experiences and using data to hone supply chain among at the conference.
The silver markets have pulled back from the $22 level during the trading session on Friday, as that area continues to offer a significant amount of resistance.
Advisors share tips to steer clear of confusing financial jargon and boost clients’ understanding of financial plans.
Some of the largest U.S. tampon makers are beefing up production to boost supplies as consumers in some parts say they cannot find their preferred products. The most prominent player with 60% of the market, Procter & Gamble Co (NYSE: PG), said it is running plants non-stop to ensure stores have an adequate supply. Edgewell Personal Care Co (NYSE: EPC) also reported production problems in the past year. Kimberly Clark Corp (NYSE: KMB), the third-largest tampon maker, said it had not experienced a